SG Americas Securities »

Aktis Oncology shares owned by SG Americas Securities

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $109k 3.4k 32.36

More positions owned by SG Americas Securities

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Meta Platforms Inc Cl A Cl A (META)
Sandisk Corp (SNDK)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Marvell Technology (MRVL)

View all positions for SG Americas Securities

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology